Neuroinnovatech ApS

Denmark

Back to Profile

1-9 of 9 for Neuroinnovatech ApS Sort by
Query
Aggregations
Date
2023 1
2021 1
2020 1
Before 2020 6
IPC Class
C07D 405/06 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms 7
C07D 231/18 - One oxygen or sulfur atom 5
C07D 231/20 - One oxygen atom attached in position 3 or 5 5
C07D 231/22 - One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms 5
C07D 231/38 - Nitrogen atoms 5
See more
Status
Pending 1
Registered / In Force 8
Found results for  patents

1.

THERAPEUTIC AGENT FOR NON-MOTOR SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE

      
Application Number 18089752
Status Pending
Filing Date 2022-12-28
First Publication Date 2023-05-18
Owner NEUROINNOVATECH APS (Denmark)
Inventor
  • Kato, Taro
  • Shimizu, Satoko

Abstract

The purpose of the present invention is to provide: a therapeutic agent or a recurrence preventive agent for serotonergic system- or dopaminergic system-related diseases, in particular, mental dysfunction symptoms and other non-motor symptoms of Parkinson’s disease; and a method for treating the aforesaid symptoms or preventing the recurrence of the same. A compound represented by formula (1) [wherein each symbol is as defined in the description] or a pharmaceutically acceptable salt thereof can exhibit an effect of treating serotonergic system- or dopaminergic system-related diseases, in particular, mental dysfunction symptoms and other non-motor symptoms of Parkinson’s disease and/or an effect of preventing the recurrence of the same. The purpose of the present invention is to provide: a therapeutic agent or a recurrence preventive agent for serotonergic system- or dopaminergic system-related diseases, in particular, mental dysfunction symptoms and other non-motor symptoms of Parkinson’s disease; and a method for treating the aforesaid symptoms or preventing the recurrence of the same. A compound represented by formula (1) [wherein each symbol is as defined in the description] or a pharmaceutically acceptable salt thereof can exhibit an effect of treating serotonergic system- or dopaminergic system-related diseases, in particular, mental dysfunction symptoms and other non-motor symptoms of Parkinson’s disease and/or an effect of preventing the recurrence of the same.

IPC Classes  ?

2.

Therapeutic agent for non-motor symptoms associated with Parkinson's disease

      
Application Number 16476925
Grant Number 11576897
Status In Force
Filing Date 2018-01-12
First Publication Date 2021-09-30
Grant Date 2023-02-14
Owner NEUROINNOVATECH APS (Denmark)
Inventor
  • Kato, Taro
  • Shimizu, Satoko

Abstract

The purpose of the present invention is to provide: a therapeutic agent or a recurrence preventive agent for serotonergic system- or dopaminergic system-related diseases, in particular, mental dysfunction symptoms and other non-motor symptoms of Parkinson's disease; and a method for treating the aforesaid symptoms or preventing the recurrence of the same. A compound represented by formula (1) [wherein each symbol is as defined in the description] or a pharmaceutically acceptable salt thereof can exhibit an effect of treating serotonergic system- or dopaminergic system-related diseases, in particular, mental dysfunction symptoms and other non-motor symptoms of Parkinson's disease and/or an effect of preventing the recurrence of the same.

IPC Classes  ?

3.

Pyrazole compound

      
Application Number 16903646
Grant Number 11312688
Status In Force
Filing Date 2020-06-17
First Publication Date 2020-10-01
Grant Date 2022-04-26
Owner NEUROINNOVATECH APS (Denmark)
Inventor
  • Sasaki, Izumi
  • Toyoda, Tomohiro
  • Yoshinaga, Hidefumi
  • Natsutani, Itaru
  • Takahashi, Yoko

Abstract

2C inverse agonistic action comprising Compound (1): 1-6 alkyl etc.; and X is hydrogen or halogen etc.

IPC Classes  ?

  • C07D 231/20 - One oxygen atom attached in position 3 or 5
  • C07D 231/18 - One oxygen or sulfur atom
  • C07D 231/38 - Nitrogen atoms
  • C07D 405/06 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
  • C07D 493/08 - Bridged systems
  • C07D 231/22 - One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
  • C07D 231/44 - Oxygen and nitrogen or sulfur and nitrogen atoms

4.

Pyrazole compound

      
Application Number 16193232
Grant Number 10723703
Status In Force
Filing Date 2018-11-16
First Publication Date 2019-03-21
Grant Date 2020-07-28
Owner NEUROINNOVATECH APS (Denmark)
Inventor
  • Sasaki, Izumi
  • Toyoda, Tomohiro
  • Yoshinaga, Hidefumi
  • Natsutani, Itaru
  • Takahashi, Yoko

Abstract

2C inverse agonistic action comprising Compound (1): 1-6 alkyl etc.; and X is hydrogen or halogen etc.

IPC Classes  ?

  • C07D 231/20 - One oxygen atom attached in position 3 or 5
  • C07D 231/44 - Oxygen and nitrogen or sulfur and nitrogen atoms
  • C07D 493/08 - Bridged systems
  • C07D 231/22 - One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
  • C07D 231/38 - Nitrogen atoms
  • C07D 231/18 - One oxygen or sulfur atom
  • C07D 405/06 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

5.

Pyrazole compound

      
Application Number 15990026
Grant Number 10183913
Status In Force
Filing Date 2018-05-25
First Publication Date 2018-09-27
Grant Date 2019-01-22
Owner NEUROINNOVATECH APS (Denmark)
Inventor
  • Sasaki, Izumi
  • Toyoda, Tomohiro
  • Yoshinaga, Hidefumi
  • Natsutani, Itaru
  • Takahashi, Yoko

Abstract

2C inverse agonistic action comprising Compound (1): 1-6 alkyl etc.; and X is hydrogen or halogen etc.

IPC Classes  ?

  • C07D 231/20 - One oxygen atom attached in position 3 or 5
  • C07D 231/18 - One oxygen or sulfur atom
  • C07D 231/38 - Nitrogen atoms
  • C07D 405/06 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
  • C07D 493/08 - Bridged systems

6.

Pyrazole compound

      
Application Number 15491130
Grant Number 10087146
Status In Force
Filing Date 2017-04-19
First Publication Date 2017-08-03
Grant Date 2018-10-02
Owner NEUROINNOVATECH APS (Denmark)
Inventor
  • Sasaki, Izumi
  • Toyoda, Tomohiro
  • Yoshinaga, Hidefumi
  • Natsutani, Itaru
  • Takahashi, Yoko

Abstract

2C inverse agonistic action comprising Compound (1): and X is hydrogen or halogen etc.

IPC Classes  ?

  • C07D 231/20 - One oxygen atom attached in position 3 or 5
  • C07D 231/38 - Nitrogen atoms
  • C07D 405/06 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
  • C07D 493/08 - Bridged systems
  • C07D 231/18 - One oxygen or sulfur atom

7.

Pyrazole compound

      
Application Number 14324509
Grant Number 09663472
Status In Force
Filing Date 2014-07-07
First Publication Date 2014-10-23
Grant Date 2017-05-30
Owner NEUROINNOVATECH APS (Denmark)
Inventor
  • Sasaki, Izumi
  • Toyoda, Tomohiro
  • Yoshinaga, Hidefumi
  • Natsutani, Itaru
  • Takahashi, Yoko

Abstract

2C inverse agonistic action comprising Compound (1): 1-6 alkyl etc.; and X is hydrogen or halogen etc.

IPC Classes  ?

  • C07D 231/44 - Oxygen and nitrogen or sulfur and nitrogen atoms
  • C07D 493/08 - Bridged systems
  • C07D 405/06 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
  • C07D 231/18 - One oxygen or sulfur atom
  • C07D 231/20 - One oxygen atom attached in position 3 or 5
  • C07D 231/38 - Nitrogen atoms
  • C07D 231/22 - One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

8.

Pyrazole compound

      
Application Number 14041246
Grant Number 08809383
Status In Force
Filing Date 2013-09-30
First Publication Date 2014-01-30
Grant Date 2014-08-19
Owner NEUROINNOVATECH APS (Denmark)
Inventor
  • Sasaki, Izumi
  • Toyoda, Tomohiro
  • Yoshinaga, Hidefumi
  • Natsutani, Itaru
  • Takahashi, Yoko

Abstract

2C inverse agonistic action comprising Compound (1): 1-6 alkyl etc.; and X is hydrogen or halogen etc.

IPC Classes  ?

  • A61K 31/415 - 1,2-Diazoles
  • C07D 405/06 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
  • C07D 231/22 - One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

9.

Pyrazole compound

      
Application Number 13810030
Grant Number 08569353
Status In Force
Filing Date 2011-07-14
First Publication Date 2013-05-09
Grant Date 2013-10-29
Owner NEUROINNOVATECH APS (Denmark)
Inventor
  • Sasaki, Izumi
  • Toyoda, Tomohiro
  • Yoshinaga, Hidefumi
  • Natsutani, Itaru
  • Takahashi, Yoko

Abstract

2C inverse agonistic action comprising Compound (1): 1-6 alkyl etc.; and X is hydrogen or halogen etc.

IPC Classes  ?

  • A61K 31/415 - 1,2-Diazoles
  • C07D 405/06 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
  • C07D 231/22 - One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms